PIB Analysis — 6 August 2026
Inventory-based Cross-border E-Commerce Export Framework Notified under FTP 2023
The Government has operationalised a dedicated policy architecture for inventory-based cross-border e-commerce exports, enabling Indian manufacturers and MSMEs to reach global markets through organised fulfilment networks without managing export formalities themselves.
India's cross-border e-commerce exports have grown rapidly, yet the sector lacked a formal policy framework. Exporters — especially artisans and small manufacturers — faced barriers in export documentation, customs clearance, international logistics, and destination-country compliance.
- Foreign Trade Policy (FTP) 2023 is the overarching framework governing India's exports and imports, administered by the Directorate General of Foreign Trade (DGFT) under the Ministry of Commerce & Industry. It replaced FTP 2015-20 and introduced a dynamic, rolling policy structure.
- FDI Policy context: The new framework follows an amendment to the FDI Policy (Press Note No. 3, 2026 Series) that permits inventory-based e-commerce operations exclusively for export purposes — a carved-out exception from the general prohibition on FDI in inventory-based B2C e-commerce in India.
- Why it matters: India's e-commerce export potential is estimated at $200–350 billion by 2030 (various industry projections). However, the absence of a regulatory framework had kept MSMEs outside the global e-commerce supply chain. This notification addresses that gap.
- Notified under: Foreign Trade Policy 2023 — Notification No. 27/2026-27 & Public Notice No. 25/2026-27 (both dated 5 August 2026)
- Nodal Ministry / Authority: Ministry of Commerce & Industry / DGFT
- Key instrument: Exporter-on-Record (EOR) model — a registered entity that procures goods from Indian Sellers-on-Record (SORs), exports in its own name, and handles all downstream compliance
- Scope: Export-only inventory operations — goods manufactured or produced in India; no diversion to domestic market permitted
- Payment timeline: Timely payment to sellers mandated irrespective of overseas buyer payment receipt
- Compliance: Annual certification, digital records, mandatory digital repository for inventory traceability
- Refunds: Export rebates (GST refunds, Duty Drawback) apportioned to sellers in proportion to their FOB value
- Seller-on-Record (SOR): An Indian manufacturer, artisan, or MSME that supplies goods to the EOR against confirmed export orders. The SOR focuses on production; the EOR handles everything post-factory-gate.
- Exporter-on-Record (EOR): A registered entity (an e-commerce platform or a third-party logistics provider) that procures goods, exports them in its own name, and is accountable for customs, labelling, certification, fulfilment, and reverse logistics.
- Speculative inventory prohibited: Export inventory may only be procured against confirmed overseas orders — no speculative stock-building for anticipated future demand.
- Traceability mandate: All inventory must be distinctly identified, segregated, and tracked in a digital repository — ensuring no diversion to the domestic market.
- Seller visibility: SORs are entitled to see the final sale price, order status, and shipment tracking of their own goods — a transparency safeguard against exploitation.
- Earlier, cross-border e-commerce exports operated under general export rules without a dedicated regulatory framework, creating ambiguity over customs valuation, GST refunds, and returns-handling.
- The FDI Policy restriction on inventory-based e-commerce (which applies to domestic sales) had also created uncertainty for foreign-invested platforms wanting to build export warehouses in India. The 2026 FDI amendment (Press Note 3) carved out an export-only exception, and this FTP notification is its operational counterpart.
- Countries such as China have explicitly built "cross-border e-commerce zones" (e.g., Hangzhou CBEC pilot, now expanded to 165 cities) that allow bonded warehousing for export fulfilment — this framework positions India to compete in that space.
- Seller bargaining power: Despite transparency mandates, SORs — typically small artisans — may lack the capacity to verify or enforce their rights against large platform EORs. The framework's effectiveness will depend on DGFT's grievance-redress mechanism, which is yet to be detailed.
- Reverse logistics risk: International return rates for apparel and fashion can exceed 30%. The EOR's obligation to re-export or return rejected goods to sellers creates a cost that could be passed back through lower procurement prices.
- Customs valuation: The EOR declares export value; the SOR's true realization may differ. Transfer-pricing-like disputes over FOB value apportionment could arise — a gap the notification does not fully address.
- Domestic market diversion: The prohibition on diverting export inventory to domestic sales requires robust enforcement — a challenge given the scale and speed of e-commerce operations.
- DGFT: Directorate General of Foreign Trade — the regulatory authority under MoCI that issues IEC (Import Export Codes), administers FTP, and issues notifications/public notices.
- FOB (Free on Board): An export pricing term where the seller bears all costs and risks up to the point goods are loaded onto the ship/aircraft at the port of export. Used as the basis for duty drawback and GST refund calculations.
- Duty Drawback: A refund of customs duties paid on imported inputs that are subsequently used in the production of exported goods — a key export incentive.
- GST Refund on Exports: Exports are zero-rated under GST; exporters can claim refund of input tax credit or pay integrated tax and claim refund.
- Press Note: The mechanism through which India's Department for Promotion of Industry and Internal Trade (DPIIT) amends the FDI Policy — Press Note 3 (2021 Series) had last amended e-commerce FDI rules.
The Inventory-based Cross-border E-Commerce Export Framework notified under FTP 2023 introduces the Exporter-on-Record model. Examine how this framework seeks to integrate Indian MSMEs and artisans into global e-commerce supply chains, and critically assess the regulatory safeguards and their limitations. 15 marks · 250 words
Indian Pharmacopoeia Commission Designated as WHO-SEARN Regional Centre of Excellence in Pharmacovigilance
The Indian Pharmacopoeia Commission has been formally recognised as the WHO South-East Asia Region's centre of excellence for pharmacovigilance and pharmaceutical quality standards — consolidating India's position as a regional leader in drug regulation.
India is the world's largest supplier of generic medicines by volume — supplying approximately 20% of global generic exports — and its drug regulatory architecture directly affects medicine quality and safety worldwide.
The IPC's recognition at the WHO-SEARN 10th Anniversary Meeting in Kathmandu (4–5 August 2026) reflects the international standing of India's pharmacopoeial and pharmacovigilance systems.
- Global context: India supplied medicines to over 200 countries and territories in FY 2024-25. The country is often called the "pharmacy of the world" — a phrase that carries both opportunity and responsibility for quality assurance.
- Regulatory backdrop: India's drug regulatory system has historically faced criticism for inadequate post-market surveillance. A series of quality failures in the early 2020s (e.g., cough syrup deaths linked to contaminated Indian exports) intensified scrutiny of Indian pharmaceutical quality systems — making this international recognition particularly significant.
- Established: 1956, as an autonomous institution; reconstituted under the Ministry of Health & Family Welfare
- Statutory basis: Drugs & Cosmetics Act, 1940 — the IPC publishes the Indian Pharmacopoeia (IP), which sets legally binding quality standards for drugs manufactured, stocked, or exhibited for sale in India
- Headquarters: Ghaziabad, Uttar Pradesh
- Key functions: Publication of Indian Pharmacopoeia (IP) editions; establishment of Indian Pharmacopoeia Reference Substances (IPRS); operation of Pharmacovigilance Programme of India (PvPI) and Materiovigilance Programme of India (MvPI); capacity building
- New designation: WHO-SEARN Regional Centre of Excellence in Pharmacovigilance AND Technical Centre in Quality of Medicines (dual recognition)
- What it is: A compendium of standards for drug substances, dosage forms, and pharmaceutical aids. A medicine marketed in India must conform to IP standards if it is IP-listed; otherwise it must comply with the standards of its country of origin or other recognised pharmacopoeias (BP, USP, Ph. Eur.).
- IP editions: The first IP was published in 1955. Subsequent editions — IP 1985, 1996, 2007, 2010, 2014, 2018, 2022 — have progressively expanded coverage, including traditional medicines and biosimilars in recent editions.
- Legal force: Section 16 of the Drugs & Cosmetics Act empowers the Central Government to specify an Indian Pharmacopoeia; Schedule P of the D&C Rules prescribes shelf life for IP-listed drugs.
- IPRS: Indian Pharmacopoeia Reference Substances are certified chemical reference standards used by quality control laboratories to test drug samples against IP specifications. India supplies IPRS to laboratories across Asia and Africa.
- Definition (WHO): Pharmacovigilance (PV) is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem.
- Pharmacovigilance Programme of India (PvPI): Launched in 2010 with WHO support; IPC is the National Coordination Centre. A network of over 400 Adverse Drug Reaction Monitoring Centres (AMCs) across India feeds reports into the national database, which is shared with the WHO global database (VigiBase) in Uppsala, Sweden.
- Materiovigilance Programme of India (MvPI): The equivalent programme for medical devices, launched in 2015 — monitoring adverse events related to medical devices.
- Signal detection: When a pattern of adverse drug reactions emerges from multiple AMC reports, IPC analyses the signal and alerts the Central Drugs Standard Control Organisation (CDSCO) for regulatory action.
- Full name: South-East Asia Regulatory Network (SEARN) — established by WHO South-East Asia Regional Office (SEARO) in 2016.
- Membership: National Regulatory Authorities of WHO SEARO member states — India, Bangladesh, Bhutan, Indonesia, Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-Leste (11 countries).
- Working groups: Quality assurance · Pharmacovigilance · Clinical trials · Regulatory preparedness · Medical device regulation.
- Objective: Strengthen regulatory systems, promote "regulatory reliance" (accepting each other's decisions rather than duplicating reviews), and improve access to quality-assured medicines across the region.
- 10th Anniversary context: Kathmandu meeting (August 2026) marked a decade of SEARN operation, during which IPC's dual designation was formalised.
- Gap between recognition and reality: India's PvPI, while large in network size, has been criticised for under-reporting — most reports come from tertiary hospitals; primary health centres contribute very little. The AMC network's quality is uneven.
- CDSCO capacity: The regulatory action arm — CDSCO — has historically been understaffed relative to the scale of India's pharmaceutical industry. Recognition of IPC's PV excellence does not directly address CDSCO's enforcement capacity.
- Regulatory reliance ambition: SEARN's goal of regional reliance (where countries accept India's quality approvals without independent review) remains aspirational. Several SEARO members retain independent review requirements for political and technical reasons.
India's Indian Pharmacopoeia Commission (IPC) has been recognised as the WHO-SEARN Regional Centre of Excellence in Pharmacovigilance. Critically examine the role of pharmacovigilance in ensuring drug safety and India's capacity to lead regional regulatory cooperation in the pharmaceutical sector. 10 marks · 150 words
NITI Aayog Releases "Reimagining Care" Report — A National Roadmap for the Caregiving Economy
NITI Aayog's "Reimagining Care" report proposes a structured national caregiving ecosystem — positioning caregiving as a formal profession with skill recognition, social security, and export potential — as India faces demographic pressures from an ageing population and a global shortage of trained caregivers.
Caregiving — the provision of support to children, the elderly, persons with disabilities, and the chronically ill — has historically been treated as an informal, feminised, and unpaid activity in India. The "care economy" remains invisible in GDP accounting despite its enormous economic value.
- Ageing India: India's elderly population (60+) is projected to reach approximately 194 million by 2031 and 347 million by 2050 — nearly 20% of the total population. This demographic shift will generate an unprecedented demand for geriatric care, home-based nursing, and rehabilitation services.
- Demographic dividend opportunity: India's working-age population (15–64) is projected to peak around 2041. Skilling this cohort in caregiving creates an export workforce opportunity — countries in East Asia, the Gulf, and Europe face severe caregiver shortages.
- ILO's care economy definition: The International Labour Organization estimates that the care economy (health, education, social work, domestic work) accounts for approximately 6.5% of global GDP and could generate 475 million jobs by 2030 if investment in care services is tripled.
- Gender dimension: Over 76% of unpaid care work globally is performed by women (ILO data). Formalising caregiving is therefore a direct instrument of women's economic empowerment.
- Title: "Reimagining Care: Strategies for Empowering Caregivers in Viksit Bharat@2047"
- Released by: Social Justice and Empowerment Division, NITI Aayog
- Prepared through: Stakeholder consultations, international benchmarking, field surveys
- Strategic pillars: Policy framework · Professional recognition · Workforce development · Global cooperation · Social security for caregivers · Family and community-based care
- Key proposals: National Policy on Caregiving; National Caregiver Council
- Overarching vision: Position India as a global hub for skilled caregiving services by 2047
- Care economy and GDP: Unpaid care work is excluded from national income accounting (GDP). Feminist economists and international bodies have long advocated for time-use surveys and satellite accounts to value and "count" care work — an issue the report engages with.
- NSSO Time-Use Survey: India's first comprehensive Time Use Survey (2019) revealed that women spend on average 299 minutes per day on unpaid domestic and care work, compared to 97 minutes for men — the data basis for policy conversations on care burden.
- Persons with Disabilities: The Rights of Persons with Disabilities Act, 2016 mandates care and support services for PwDs; NITI's report links professional caregiving to the implementation architecture of this Act.
- National Action Plan for Skill Development of Persons with Disabilities: Existing skilling frameworks under MoSDE address PwD-related caregiving — the report seeks convergence between such schemes and a dedicated caregiving profession.
- Skill India Mission: Launched 2015; PMKVY (Pradhan Mantri Kaushal Vikas Yojana) under the National Skill Development Corporation (NSDC) currently includes short courses in home-based caregiving and elderly care — precursors to what the report seeks to formalise and scale.
- National Policy for Senior Citizens 2011 → Proposed revision: The existing National Policy for Senior Citizens (2011) does not address professional caregiving systematically; a revised policy has been under discussion since the late 2010s — this report is likely to inform that revision.
- Japan: Faces a shortage of approximately 690,000 care workers by 2030 — has opened a specific visa category (Specified Skilled Worker) for foreign caregivers; India is a potential supplier.
- GCC countries: Already employ large numbers of Indian domestic workers, many of whom perform informal caregiving. Formalisation and skill certification would improve wages, working conditions, and bilateral social security arrangements.
- Germany & Europe: Germany's Skilled Immigration Act (2020, expanded 2023) allows foreign caregivers on simplified pathways. European ageing demographics make this a growing market.
- India's soft-power angle: The report specifically invokes India's traditions of seva (selfless service) and samvedana (compassion) as cultural differentiators in global caregiving markets — a soft-power framing consistent with India's brand of civilisational diplomacy.
- Risk of export-orientation over domestic care: Prioritising skilled caregiver exports could exacerbate domestic shortages — a pattern seen in the nursing sector, where trained nurses migrate abroad, leaving rural India underserved.
- Social security gap: Informal domestic caregivers — the vast majority today — have no access to ESIC, EPF, or other social security schemes. A National Caregiver Council without mandatory social security portability would leave this gap unaddressed.
- Gender neutrality challenge: Professionalising caregiving may continue to be gendered in practice. Without affirmative inclusion of male caregivers and community health workers (ASHA, Anganwadi), the profession risks remaining a feminised, low-status occupation despite formal recognition.
- Implementation convergence: The report involves at least six ministries (Health, Social Justice, Skill Development, External Affairs, WCD, Labour). Inter-ministerial coordination in India has historically been a weak link in social sector implementation.
India's caregiving economy remains largely informal, feminised, and invisible in national income accounts. In the light of NITI Aayog's "Reimagining Care" report, critically examine the social, economic, and demographic imperatives for professionalising caregiving in India, and the challenges of implementing a national caregiving policy. 15 marks · 250 words


